BIOPLATFORMS AUSTRALIA
Advancing life science through biomolecular infrastructure and national collaboration
RESEARCH FACILITIES
Effective results-driven research requires a critical mass of expertise and state-of-the-art infrastructure for the Australian life sciences sector.
Through Bioplatforms’ infrastructure and personnel investment we ensure highly skilled researchers have access to world-class technology platforms.
GENOMICS
Gene discovery and function
PROTEOMICS
Protein structure and function
METABOLOMICS
Small molecule analysis
SYNTHETIC BIOLOGY
New product incubation
BIOINFORMATICS
The Australian BioCommons
DATA RESOURCES
National-scale open-access collections
NATIONAL CHALLENGES
Our National Framework Initiatives catalyse research collaborations to build new capabilities and critical data resources to support some of Australia’s biggest scientific challenges. These challenges span primary industry and food, biomedicine, the nature and environment.
ACCELERATING TRANSLATION AND RESEARCH IMPACT
Leveraging Bioplatforms established infrastructure, network, reputation, and funding to accelerate translation and commercialisation of Australian research for social, environmental, or economic benefit.
NEWS
The Integrated Pest Management Omics (IPM Omics) Initiative is pleased to announce that the 2025 Request for...
Bioplatforms Australia and Phenomics Australia are proud to announce a new national initiative aimed at advancing knowledge of causality and...
Bioplatforms Australia is collaborating with Therapeutic Innovation Australia (TIA), Phenomics Australia, and the Australian Nuclear Science and...
The 2024 Nobel Prize in Chemistry was awarded to the team behind the transformative AI tool AlphaFold. In a major achievement for life sciences and...
REQUEST FOR PARTNERSHIP GUIDELINES Background and Aims Today’s complex communities of rangeland grasses have evolved to dominate much of the...
We are excited to announce the opening of the Request for Partnership for the Australian Grasslands Initiative. This collaborative effort seeks to...
Bioplatforms Australia, enabled by NCRIS investment in research infrastructure, is committed to supporting the Australian life sciences community...
Bioplatforms Australia, in collaboration with Minderoo Foundation, is pleased to announce the opening of the 2024 Request for Partnership for the...
EMBL Australia has signed a Memorandum of Understanding (MOU) to join the NCRIS Health Group, strengthening Australian collaborative health...
The Bioplatforms Australia-supported Plant Pathogen ‘Omics Initiative was initiated in 2022 and is working to generate a national...